The objective of this study is to implement an intervention in a pragmatic randomized controlled trial that uses cancer treatment pathways data to identify patients appropriate for serious illness conversations (SICs) and applies nudges to patients and their oncology clinicians to increase SICs and improve end of life (EOL) outcomes.~Identified participants and clinicians will be randomized into 1 or 4 groups.~Nudge to patient and clinician~Nudge to patient only~Nudge to clinician only~No nudge.~The expected enrollment is approximately 800 participants.
The purpose of this study is to increase serious illness conversations (SICs) about patients goals and preferences regarding their healthcare between patients with cancer and their oncology clinicians and improved care provided near the end of life.